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Background and aim: The general practitioner (GP) is the first contact with the health care 
system for most patients with COPD in Denmark. We studied, if participating in an educational 
program could improve adherence to guidelines, not least for diagnosis, staging, and treatment 
of the disease.
Design and setting: Two cross-sectional surveys were performed precisely one year apart 
before and after an educational program for the participating GPs. A total of 124 GPs completed 
the study; 1716 and 1342 patients with GP-diagnosed COPD and no concomitant asthma, 
respectively, were included in the two surveys.
Results: The proportion of patients having FEV1 registered in the GPs files increased from 45% 
to 69% (P  0.001); and, furthermore, FEV1 % of predicted was recorded in 30% and 56%, 
respectively, of the cases (P  0.001). In line with this, significant improvements were also 
observed for registration of smoking status (69% to 85%), BMI (8% to 40%), severity of dyspnea 
(Medical Research Council) (7% to 38%), and FEV1/FVC ratio (28% to 58%) (P  0.001). Con-
cerning the management options, improvements were also observed with regard to antismoking 
counseling, inhalator technique, physical activity, and referral for rehabilitation; use of inhaled 
corticosteroids in patients with mild COPD (FEV1  80%pred) declined from 76% to 45%.
Conclusion: Diagnosis and management of COPD in general practice in Denmark is not 
according to guidelines, but substantial improvements can be achieved by focused education 
of GPs and their staff.
Keywords: COPD, guidelines, adherence, education, diagnosis, management
Introduction
Chronic obstructive pulmonary disease (COPD) is a major health problem, not least 
in industrialized countries, and it has recently been estimated that Denmark, with 
approximately 5.5 million inhabitants, has more than 300,000 patients suffering from 
COPD,1 and, like in many countries, a substantial proportion of patients are diagnosed 
in advanced stages of the disease.2,3 Furthermore, approximately 20% of acute admis-
sions to hospitals in Denmark are due to exacerbations of COPD.2
According to the GOLD-guidelines,3 COPD is both a preventable and treatable 
disease; and, therefore, more focus on diagnosis, staging and management, including 
smoking cessation programs and pharmacological treatment, may reduce the overall 
burden of COPD.3,4 Furthermore, over the recent decades, several sets of national5 
and international3,4 guidelines have recommended spirometry and adherence to International Journal of COPD 2010:5 74
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documented management algorithms with the aim of 
improving the overall care for patients suffering from COPD. 
However, previous studies have documented that GPs, in 
spite of these available resources, do not find it easy to 
diagnose and treat COPD.6
In Denmark, as well as in many other countries, the 
general practitioner (GP) often represents the first contact 
of a COPD patient with the health care system; and, there-
fore, in order to improve the care of patients with COPD, 
it seems of outmost importance to improve the knowledge 
and skills related to diagnosing and managing this common 
disease among GPs.
In the present study, we therefore studied if participat-
ing in an educational program may improve adherence to 
guidelines, not least for diagnosis, staging, and subsequently, 
pharmacological treatment of COPD.
Methods
The present study, KVASIMODO II, consisted of two 
descriptive cross-sectional investigations focusing on the 
quality of care for patients suffering from COPD in general 
practice. The initial audit survey of the participating GPs’ 
patient files (Survey 1) was conducted on recorded patient 
data obtained before the GP had knowledge of the study, and, 
after consenting, the GPs and their staff followed an educa-
tional program, where after a second audit survey (Survey 2) 
was conducted exactly 12 months after the first survey.
The primary efficacy parameter was the proportion of 
patients with spirometric data, and by that correct diagnosis 
and staging; and the secondary parameters included changes 
in monitoring of dyspnea score (Medical Research Council 
[MRC],7 referral for rehabilitation, instruction in use of 
inhalator-devices, body mass index (BMI [kg/m2]), and anti-
smoking counseling.
Denmark has approximately 3600 GPs, covering a 
population of 5.5 million, and we aimed to include, on a 
voluntary basis, up to 200 GPs in the study from all over 
Denmark. Written information about the project and the 
invitation to participate was distributed by the sponsoring 
companies’ representatives. Each of the participating GPs 
had to identify 20 COPD consecutive patients who attended 
his or her practice from March 1st to June 30th, 2006 (Sur-
vey 1) and 20 consecutive patients during a similar period 
in 2007 (Survey 2).
The case definition of COPD was based on expert opinion 
as follows: Age  35 years, and at least two prescriptions for 
an inhaled bronchodilator (short- or long-acting β2 agonist, 
short- or long-acting anti-cholinergic drug, or, a combination 
of the two) within the previous year. Patients who were, by 
the GP, considered to have asthma were excluded from the 
study.
This practical definition of COPD was chosen, instead of 
a spirometry-based definition, because evidence from a pre-
vious study6 showed that the implementation of spirometry 
testing was relatively low. Furthermore, this approach gave us 
the opportunity to investigate how often treatment for COPD 
is initiated without a verified diagnosis, ie, spirometry, and 
also potentially made it easier for the participating GPs since 
prescribing data are always recorded.
After identifying 20 cases of COPD, the GP was asked to 
perform an internal audit of the information already available 
in his/her clinical files in order to fill in the clinical record 
form (CRF) for each of the included patients. No additional 
patient investigation was allowed in order to complete the 
CRF, so if the requested information was not available a 
missing value was recorded.
The CRF consisted of 5 parts: inclusion criteria, exclu-
sion criteria, diagnostic procedures, non-pharmacological 
treatment, and pharmacological treatment. All data from 
the individual CRF were entered into a consolidated web-
based database by the GP or, in most cases, by a member of 
their staff. Quality control of the CRFs was performed by 
consultants from the sponsoring companies.
The education program on COPD, which took place 
between the two surveys, was based on the GOLD-guidelines 
and was designed by a group of Danish pulmonologists and 
GPs with a special interest in COPD (ie, the steering commit-
tee of the KVASIMODO II study). It was directed towards the 
participating GPs and their staff, including nurses, laboratory 
technicians, and secretaries, and consisted of the following 
components: 1) An individual meeting with a consultant from 
one of the sponsoring companies focusing on the GOLD-
guidelines, 2) Local meetings with GPs and their staff, where 
two from the steering committee, a pulmonologist and a 
GP, discussed several aspects of the guidelines, 3) Regional 
symposiums for the participating GPs and their staff. The 
symposium consisted of plenary sessions and workshops, 
and included practical issues like performing and interpreting 
spirometry and the teaching of inhaler technique, and, subse-
quently, 4) An individual meeting with a consultant from one 
of the sponsoring companies focusing on the participating 
GPs data, and, not least, changes over the study period, and 
5) A final meeting for all participating GPs and their staff, 
where the results of the study were presented. All participat-
ing GPs and their staffs were offered the same educational 
program, both quantitatively and qualitatively.International Journal of COPD 2010:5 75
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Data analysis
Data from individual patient records were analyzed focusing 
on the overall quality of care according to the previously 
defined outcome variables; only patient data provided by GPs 
who completed both surveys were included in the analyses. 
The FEV1 was expressed as a percentage of the predicted 
value,8 and the FEV1/FVC ratio as the absolute value. The 
chi-square test and Mann–Whitney two-sample test were 
used, as appropriate. The KVASOMODO II project was rec-
ommended and approved by the Danish College of General 
Practitioners.
Results
A total of 194 GPs were interested in participating in the 
KVASIMODO II study. However, during the two surveys 42 
and 28 GPs, respectively, dropped out of the study, primarily 
due to difficulties in retrieving patient data from their files 
and excessive daily workload. The final analyses, therefore, 
comprised data provided by 124 GPs, and included 1716 
and 1342 patients, respectively. More females than males 
were included in the study, but mean age for both genders 
were 68 years, and mean FEV1 – in patients with available 
information on age, height, and spirometry – was 59% of 
the predicted value; further details are given in Table 1. At 
the start of survey 1 more than 85% of the GPs had direct 
access to a spirometer.
Table 2 shows the results of both audit surveys, ie, the 
presence of relevant information in the GPs files on indices 
related to diagnosing and staging of their patients suffering 
from COPD. At survey 1, only 45 % of the CRFs included 
relevant spirometric data (FEV1, FVC, and FEV1/FVC ratio), 
whereas the corresponding figures were 69 % at the 2. survey 
(P  0.001). Furthermore, only 21 % of the included patients 
in survey 1 fulfilled the diagnostic criteria of an FEV1/FVC 
ratio  70%, whereas 48 % of the patients included in 
survey 2 by definition had airway obstruction (P  0.001). 
The FEV1 as a percentage of predicted value (requiring data 
on FEV1, age, and height) was only available for 30% and 
56%, respectively, of the included patients at the two surveys 
(P  0.001); and the observed correlation between severity 
of disease as judged by the GP and FEV1 %pred was not 
optimal (Figure 1).
Improvements in several indices of adherence to guide-
lines for pharmacological and non-pharmacological manage-
ment were observed from survey 1 to survey 2 (Table 3), 
including a significant fall in the proportion of patients with 
mild COPD treated with inhaled corticosteroids (P  0.01) 
(Figure 2), especially in patients with available information 
in the GPs file on FEV1 %pred (76% and 45%, respectively; 
P  0.001) (Figure 3).
Discussion
This study shows that participating in an educational program 
can substantially improve adherence to COPD guidelines 
by general practitioners, even though there is still room for 
improvement with regard to care for patients suffering from 
COPD in general practice in Denmark.
Our study confirms findings from a previously pub-
lished similar study.6 However, in contrast to the study by 
Lange et al,6 the present study included younger subjects 
(35 years) and excluded patients with concomitant asthma. 
These differences have most likely improved our possibility 
to evaluate real life care of COPD patients in general practice 
in Denmark, not least for pharmacological treatment due to 
the exclusion of patients with doctor-diagnosed concomitant 
asthma. In line with this, it also offered us the opportunity 
to investigate the quality of care for younger patients with 
doctor-diagnosed COPD, where the clinical picture will pos-
sibly more likely lead to a diagnosis of asthma.
GPs were recruited for the study from all over Denmark, 
but because participation in the study was voluntary, 
the enrolled GPs might not be representative of the GPs 
in Denmark, especially with regard to motivation for 
Table 1 Characteristics of the patients suffering from COPD 
enrolled in the first and second survey
First survey Second survey
number of gPs 124 124
number of patients 1716 1342
Mean age (range) 68 (35–95) 68 (35–97)
Male/Female ratio 44/56% 48/52%
Smoking, pack-years (range) 40 (1–110) 40 (3–120)
Body mass index, kg/m2 (range) 27 (15–44) 26 (15–48)
Dyspnea index, MRC (range) 3 (1–5) 3 (1–5)
Abbreviation: MRC, Medical Research Council.
Table 2 Presence of information in the patient files related to 
diagnosis and staging of COPD for the patients included in the 
study by the 124 gPs who participated in both surveys
Survey 1 Survey 2
Smoking status 69% 85%*
Tobacco exposure (pack-years) 14% 40%**
FeV1 (L) 45% 69%**
FeV1 (%pred) 30% 56%**
FeV1/FVC  70% 21% 48%**
For comparison between survey 1 and 2: *P  0.01, and **P  0.001International Journal of COPD 2010:5 76
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improvement in their personal management of patients with 
COPD. However, due to the fact that a very similar study 
had previously been conducted in Denmark,6 it seems likely 
that the GPs recruited for the present study, on average, 
had less interest in COPD and lung diseases, as GPs were 
excluded from the present study if they had participated in 
the previous study.6
Patients were included on the basis of prescription 
of inhaled bronchodilators, age, and absence of asthma. 
This practical definition, instead of a spirometry-based 
definition, was chosen, because one of the major problems 
in implementation of COPD guidelines in general practice is 
difficulties in using spirometry, most likely primarily due to 
the mandatory active patient participation, calibration of spi-
rometer, and interpretation of results.9 However, although this 
improved our ability to evaluate the main outcome of the study, 
it might have excluded some patients with milder COPD, as 
they may not have been prescribed bronchodilators.9,10
Our primary aim was to promote spirometry, and by that 
correct diagnosis and staging, which is mandatory in the man-
agement of COPD.3,4 Performing spirometry is easy, cheap, 
and takes only a few minutes,11 and it should, therefore, be 
FEV1 %pred
Clinical staging
1st survey 2nd survey
MILD
MODERATE
SEVERE
VERY
SEVERE
MILD MODERATE UNKNOWN
100
80
60
40
20
0
SEVERE VERY SEVERE
Figure 1 Level of FeV1 %pred versus clinical staging of COPD (as judged by the individual patient’s GP based on symptom severity) in the first and the second survey.
Table 3 Presence of information in the patient files related to adherence to COPD guidelines for the patients included in the study by 
the 124 gPs who participated in both surveys
Survey 1 Survey 2
BMI (kg/m2)
Dietary instruction given (BMI  20)
8%
38%
40%**
59%*
Smoking cessation advice given (smokers only) 40% 57%*
Instruction in inhalation technique documented 25% 41%*
Dyspnea score recorded (MRC) 7% 38%**
Referred for COPD rehabilitation 12% 16%a
Inhaled corticosteroids in mild COPD 76% 45%**
Inhaled corticosteroids in severe COPD 86% 85%a
For comparison between survey 1 and 2: anS, *P  0.01, and **P  0.001.
Abbreviations: BMI, body mass index; MRC, Medical Research Council.International Journal of COPD 2010:5 77
Mangement of COPD in general practice Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
1. 1st survey
2nd survey
Percentage of patients (n = 53)
Percentage of patients (n = 67)
NS NS NS NS P < 0.01 NS NS NS
100
80
60
40
20
0
100
80
60 54%
42%
1%
27%
18%
0% 3% 4%
IPR, SABA TIO, LABA THEO LABA/ICS ICS LABA/ICS & ICS PO MUC
IPR, SABA TIO, LABA THEO LABA/ICS ICS LABA/ICS & ICS PO MUC
58%
38%
4%
40% 42%
6% 2% 6%
40
20
0
Figure 2 Prescribed pharmacological treatment for patients with mild COPD in the first and the second survey.
Abbreviations: IPR, ipratropium bromide; Tio, tiotropium; LABA, long-acting β2 agonist;   Theo, theophylline; ICS, inhaled corticosteroids; PO, oral prednisolone; MUC, mucolytics.
1st survey
2nd survey
Percentage of patients
Percentage of patients
P < 0.001
75% 76% 81%
88%
75% 76%
45%
100
80
60
40
20
0
100
80
60
40
20
0
59%
81%
90%
74% 70%
P < 0.001 NS NS NS P < 0.001
Mild Moderate Severe Very severe Unknown Total
Mild Moderate Severe Very severe Unknown Total
Figure 3 Prescribed treatment inhaled corticosteroids according to severity of COPD based on measurement of FeV1 in the first and the second survey.International Journal of COPD 2010:5 78
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possible to offer spirometry to all individuals suspected to 
suffer from COPD. Furthermore, in Denmark, spirometry is 
reimbursed and the majority of Danish GPs (85%) have 
direct access to a spirometer. Although all patients enrolled 
in the present study had doctor-diagnosed COPD, and were 
treated with inhaled bronchodilators, spirometry data from 
survey 1 documented the presence of airway obstruction 
(FEV1/FVC  70%) in only 21% of the cases. In line with 
this, a severity assessment, based on FEV1 %pred, was only 
available in 30% of the cases. Our study therefore confirm 
previous findings that spirometry is often underused in gen-
eral practice;12–14 and this might be one of the main barriers 
for implementation of GOLD guidelines and/or national 
COPD guidelines. Fortunately, a significant improvement 
in these figures were observed at survey 2 (48% and 56%, 
respectively), but remained substantially lower than found in 
other comparable studies9,10,15 although the majority of the 
GPs who participated in the study actually had a spirometer 
in their practice.
It has previously been shown that inaccurate diagnosis 
and staging of COPD leads to inadequacy of administered 
treatments, including non-pharmacological management.9,10,15 
Bourbeau et al10 identified, looking at data reported by a large 
number of GPs, that the pharmacological treatment matched 
guideline recommendations in only 35% of the patients. This 
obvious discrepancy between prescribed therapy and guideline 
recommendations of therapy tailored to disease severity was 
also observed in the present study (Figure 1).
In contrast to bronchodilators, inhaled corticosteroids 
were, at the time of this study, only recommended to patients 
with severe and very severe COPD experiencing repeated 
exacerbations.3,4 With regard to pharmacological treatment, 
we therefore decided to focus on the use of inhaled corti-
costeroids. Survey 1 showed that inhaled corticosteroids 
were prescribed for 76% of the patients with mild COPD, 
which is comparable to figures reported by Bourbeau et al10 
Furthermore, Jones et al9 has reported that inhaled cortico-
steroids are overprescribed for COPD in general practice 
(recommended for 17%, taken by 60%). The education 
program in the present study included information on the 
evidence-based recommended pharmacological and non-
pharmacological treatment, and in accordance with this we 
observed an improvement in most relevant indices, including 
the use of inhaled corticosteroids (Table 3, Figure 2). In keep-
ing with previous findings from Denmark by Schaefer et al,16 
it is therefore possible, through education, to change GPs’ 
prescription patterns without interfering with patient access 
to relevant treatment or with GPs’ clinical freedom.
In addition to describing the overall quality of care for 
patients suffering from COPD, we also wanted to evaluate if 
participation in an educational program can improve adher-
ence to guidelines, and by that improve the quality of care. 
Similar to other studies,9,10 the method used was an internal 
audit. Since the GPs themselves completed the CRFs, we 
cannot exclude an element of ‘observer bias’, especially 
during survey 2, although some cross-checking was done 
on a random sample of the cases included.
In conclusion, this study showed that diagnosis, stag-
ing, and management, including pharmacological and non-
pharmacological treatment, is not according to guidelines in 
general practice in Denmark, but substantial improvements 
can be achieved in most relevant indices of quality of care 
of this very common chronic disease through educating the 
GPs and their staff. Further studies are needed in order to 
ascertain how the achieved improvements can be maintained 
and expanded.
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